COVID-19 Impact on Global Chronic Myeloid Leukemia (CML) Treatment Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Chronic Myeloid Leukemia (CML) Treatment Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Targeted Therapy
  • 1.4.3 Chemotherapy
  • 1.4.4 Radiation Therapy
  • 1.4.5 Splenectomy
  • 1.4.6 Stem Cell Transplant
• 1.5 Market by Application
  • 1.5.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinic
  • 1.5.4 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Chronic Myeloid Leukemia (CML) Treatment Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Chronic Myeloid Leukemia (CML) Treatment Industry
    • 1.6.1.1 Chronic Myeloid Leukemia (CML) Treatment Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Chronic Myeloid Leukemia (CML) Treatment Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Chronic Myeloid Leukemia (CML) Treatment Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Chronic Myeloid Leukemia (CML) Treatment Market Perspective (2015-2026)
• 2.2 Chronic Myeloid Leukemia (CML) Treatment Growth Trends by Regions
  • 2.2.1 Chronic Myeloid Leukemia (CML) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Chronic Myeloid Leukemia (CML) Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Chronic Myeloid Leukemia (CML) Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Chronic Myeloid Leukemia (CML) Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Market Size
  • 3.1.1 Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Chronic Myeloid Leukemia (CML) Treatment Market Concentration Ratio
  • 3.2.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Chronic Myeloid Leukemia (CML) Treatment Revenue in 2019
• 3.3 Chronic Myeloid Leukemia (CML) Treatment Key Players Head office and Area Served
• 3.4 Key Players Chronic Myeloid Leukemia (CML) Treatment Product Solution and Service
• 3.5 Date of Enter into Chronic Myeloid Leukemia (CML) Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Chronic Myeloid Leukemia (CML) Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Type (2021-2026)

5 Chronic Myeloid Leukemia (CML) Treatment Breakdown Data by Application (2015-2026)

• 5.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
• 5.2 Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
• 6.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in North America (2019-2020)
• 6.3 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
• 6.4 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
• 7.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
• 7.4 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
• 8.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in China (2019-2020)
• 8.3 China Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
• 8.4 China Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
• 9.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
• 9.4 Japan Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
• 10.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
• 11.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in India (2019-2020)
• 11.3 India Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
• 11.4 India Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
• 12.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Novartis AG
  • 13.1.1 Novartis AG Company Details
  • 13.1.2 Novartis AG Business Overview and Its Total Revenue
  • 13.1.3 Novartis AG Chronic Myeloid Leukemia (CML) Treatment Introduction
  • 13.1.4 Novartis AG Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020))
  • 13.1.5 Novartis AG Recent Development
• 13.2 Bristol-Myers Squibb
  • 13.2.1 Bristol-Myers Squibb Company Details
  • 13.2.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  • 13.2.3 Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Introduction
  • 13.2.4 Bristol-Myers Squibb Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
  • 13.2.5 Bristol-Myers Squibb Recent Development
• 13.3 Teva Pharmaceuticals Industries Ltd.
  • 13.3.1 Teva Pharmaceuticals Industries Ltd. Company Details
  • 13.3.2 Teva Pharmaceuticals Industries Ltd. Business Overview and Its Total Revenue
  • 13.3.3 Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Introduction
  • 13.3.4 Teva Pharmaceuticals Industries Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
  • 13.3.5 Teva Pharmaceuticals Industries Ltd. Recent Development
• 13.4 ARIAD Pharmaceuticals, Inc.
  • 13.4.1 ARIAD Pharmaceuticals, Inc. Company Details
  • 13.4.2 ARIAD Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  • 13.4.3 ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Introduction
  • 13.4.4 ARIAD Pharmaceuticals, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
  • 13.4.5 ARIAD Pharmaceuticals, Inc. Recent Development
• 13.5 Pfizer, Inc.
  • 13.5.1 Pfizer, Inc. Company Details
  • 13.5.2 Pfizer, Inc. Business Overview and Its Total Revenue
  • 13.5.3 Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Introduction
  • 13.5.4 Pfizer, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
  • 13.5.5 Pfizer, Inc. Recent Development
• 13.6 Hospira, Inc.
  • 13.6.1 Hospira, Inc. Company Details
  • 13.6.2 Hospira, Inc. Business Overview and Its Total Revenue
  • 13.6.3 Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Introduction
  • 13.6.4 Hospira, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
  • 13.6.5 Hospira, Inc. Recent Development
• 13.7 Prism Pharmaceuticals
  • 13.7.1 Prism Pharmaceuticals Company Details
  • 13.7.2 Prism Pharmaceuticals Business Overview and Its Total Revenue
  • 13.7.3 Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Introduction
  • 13.7.4 Prism Pharmaceuticals Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
  • 13.7.5 Prism Pharmaceuticals Recent Development
• 13.8 Incyte Corporation
  • 13.8.1 Incyte Corporation Company Details
  • 13.8.2 Incyte Corporation Business Overview and Its Total Revenue
  • 13.8.3 Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Introduction
  • 13.8.4 Incyte Corporation Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
  • 13.8.5 Incyte Corporation Recent Development
• 13.9 Bio-Path Holdings
  • 13.9.1 Bio-Path Holdings Company Details
  • 13.9.2 Bio-Path Holdings Business Overview and Its Total Revenue
  • 13.9.3 Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Introduction
  • 13.9.4 Bio-Path Holdings Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
  • 13.9.5 Bio-Path Holdings Recent Development
• 13.10 Stragen Pharma SA
  • 13.10.1 Stragen Pharma SA Company Details
  • 13.10.2 Stragen Pharma SA Business Overview and Its Total Revenue
  • 13.10.3 Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Introduction
  • 13.10.4 Stragen Pharma SA Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
  • 13.10.5 Stragen Pharma SA Recent Development
• 13.11 Otsuka Pharmaceutical Co., Ltd.
  • 10.11.1 Otsuka Pharmaceutical Co., Ltd. Company Details
  • 10.11.2 Otsuka Pharmaceutical Co., Ltd. Business Overview and Its Total Revenue
  • 10.11.3 Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Introduction
  • 10.11.4 Otsuka Pharmaceutical Co., Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
  • 10.11.5 Otsuka Pharmaceutical Co., Ltd. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer